...
首页> 外文期刊>Clinical cancer research: an official journal of the American Association for Cancer Research >Multiple mechanisms of telomere maintenance exist and differentially affect clinical outcome in diffuse malignant peritoneal mesothelioma.
【24h】

Multiple mechanisms of telomere maintenance exist and differentially affect clinical outcome in diffuse malignant peritoneal mesothelioma.

机译:存在端粒维持的多种机制,并在弥漫性恶性腹膜间皮瘤中差异影响临床结果。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: This study aims to investigate the prevalence of the two known telomere maintenance mechanisms, telomerase activity (TA) and alternative lengthening of telomeres (ALT), and to assess their prognostic relevance in diffuse malignant peritoneal mesothelioma (DMPM). EXPERIMENTAL DESIGN: In 44 DMPM specimens obtained from 38 patients, TA was determined using the telomeric repeat amplification protocol and ALT was detected by assaying ALT-associated promyelocytic leukemia nuclear bodies. The prognostic significance of telomere maintenance mechanisms was analyzed by Cox regression in the overall series and in a subset of 29 patients who underwent a uniform treatment regimen consisting of cytoreductive surgery and hyperthermic i.p. chemotherapy. RESULTS: Telomere maintenance mechanisms were detectable in 86.4% of DMPM: ALT or TA alone was found in 18.2% or 63.6% of lesions, respectively, whereas two cases (4.6%) were ALT+/TA+. TA and ALT proved to be inversely associated (P = 0.002). In the overall series, TA was prognostic for 4-year relapse (TA+ versus TA-, hazard ratio, 3.30; 95% confidence interval, 1.23-8.86; P = 0.018) and cancer-related death (TA+ versus TA-, hazard ratio, 3.56; 95% confidence interval, 1.03-12.51; P = 0.045), whereas ALT failed to significantly affect clinical outcome. These results held true also in the subset of patients submitted to uniform treatment with cytoreductive surgery and hyperthermic i.p. chemotherapy. CONCLUSIONS: Our results indicate that both known telomere maintenance mechanisms, TA and ALT, are present in DMPM and differentially affect patient prognosis.
机译:目的:本研究旨在调查两种已知的端粒维持机制(端粒酶活性(TA)和端粒的替代性延长(ALT))的发生率,并评估它们在弥漫性恶性腹膜间皮瘤(DMPM)中的预后相关性。实验设计:在38例患者的44份DMPM标本中,使用端粒重复扩增方案确定TA,并通过测定ALT相关的早幼粒细胞白血病核体来检测ALT。端粒维持机制的预后意义在整个系列研究中以及在29位接受了细胞减灭术和高温热腹膜内治疗的统一治疗方案的患者的亚组中进行了Cox回归分析。化学疗法。结果:在86.4%的DMPM中可检测到端粒维持机制:仅ALT或TA分别占病变的18.2%或63.6%,而2例(4.6%)为ALT + / TA +。 TA和ALT呈负相关(P = 0.002)。在整个系列中,TA预后为4年复发(TA +与TA-,危险比为3.30; 95%置信区间为1.23-8.86; P = 0.018)和癌症相关死亡(TA +与TA-,危险比) ,3.56; 95%置信区间:1.03-12.51; P = 0.045),而ALT未能显着影响临床结局。这些结果在接受细胞减灭术和高温i.p统一治疗的患者子集中也是如此。化学疗法。结论:我们的结果表明,DMPM中存在两种已知的端粒维持机制TA和ALT,它们分别影响患者的预后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号